Graftys SAS - Product Pipeline Analysis, 2015 Update

Date: May 26, 2015
Pages: 21
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G6E275B12F9EN
Leaflet:

Download PDF Leaflet

Graftys SAS - Product Pipeline Analysis, 2015 Update
Summary

Graftys SAS (Graftys) is a medical technology company that focuses on bone tissue engineering. It carries out design, manufacture and marketing of calcium phosphate based synthetic bone substitutes. The company’s product portfolio caters to the areas of ortho-trauma, spine and dental surgery. Graftys research and development projects include the bone substitutes combined with therapeutic agents, latest generation of injectable and resorbable synthetic bone substitutes, and biological repair of cartilage and the spine. It markets its products through brands such as Bioactys, and Graftys. The company operates its research and development facility in Nantes, Franceand commercial office in Chicago, the US. Graftys is headquartered in Aix en Provence, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Graftys SAS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Graftys SAS Company Snapshot
Graftys SAS Company Overview
Key Information
Graftys SAS Pipeline Products and Clinical Trials Overview
Graftys SAS – Pipeline Analysis Overview
Key Facts
Graftys SAS - Major Products and Services
Graftys SAS Pipeline Products by Development Stage
Graftys SAS Pipeline Products Overview
3D Matrix
3D Matrix Product Overview
Injectable Resorbable Material
Injectable Resorbable Material Product Overview
Intelligent Bone Substitute - Infection
Intelligent Bone Substitute - Infection Product Overview
Intelligent Bone Substitute - Osteoporosis
Intelligent Bone Substitute - Osteoporosis Product Overview
Intelligent Bone Substitute - Pain
Intelligent Bone Substitute - Pain Product Overview
Phosphocalcic Cement
Phosphocalcic Cement Product Overview
Graftys SAS - Key Competitors
Graftys SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Graftys SAS, Recent Developments
Jan 06, 2010: Graftys To Exhibit At AAOS 2010
Aug 28, 2008: Graftys Filed Graftys HBS To FDA
Jul 25, 2008: Graftys Announces Launch Of Graftys HBS
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Graftys SAS, Key Facts
Graftys SAS Pipeline Products and Clinical Trials Overview
Graftys SAS Pipeline Products by Equipment Type
Graftys SAS Pipeline Products by Indication
Graftys SAS, Key Facts
Graftys SAS, Major Products and Services
Graftys SAS Number of Pipeline Products by Development Stage
Graftys SAS Pipeline Products Summary by Development Stage
3D MATRIX - PRODUCT STATUS
3D MATRIX - PRODUCT DESCRIPTION
Injectable Resorbable Material - Product Status
Injectable Resorbable Material - Product Description
Intelligent Bone Substitute - Infection - Product Status
Intelligent Bone Substitute - Infection - Product Description
Intelligent Bone Substitute - Osteoporosis - Product Status
Intelligent Bone Substitute - Osteoporosis - Product Description
Intelligent Bone Substitute - Pain - Product Status
Intelligent Bone Substitute - Pain - Product Description
Phosphocalcic Cement - Product Status
Phosphocalcic Cement - Product Description
Graftys SAS, Other Locations
Graftys SAS, Subsidiaries

LIST OF FIGURES

Graftys SAS Pipeline Products by Equipment Type
Graftys SAS Pipeline Products by Development Stage
Skip to top


Ask Your Question

Graftys SAS - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: